New Launch11 Jul 2025, 07:11 pm
Indegene Unveils NEXT Medical Writing Automation to Revolutionize Life Sciences Documentation
AI Summary
Indegene, a digital-first, life sciences commercialization company, announced the launch of NEXT Medical Writing Automation. This advanced platform combines deep medical writing expertise with generative AI (GenAl) to accelerate the creation of high-quality, compliant documents across clinical development, regulatory submissions, and beyond. The platform, built on Indegene's Cortex AI engine, helps life sciences organizations scale operations efficiently while maintaining a strong compliance backbone.
Key Highlights
- Indegene launches NEXT Medical Writing Automation, an advanced platform that combines deep medical writing expertise with generative AI (GenAl).
- The platform is built on Indegene's Cortex AI engine, a life sciences-specialist knowledge engineering and multi-agent orchestration platform.
- NEXT Medical Writing Automation operates within familiar environments like Microsoft Word, auto-generating compliant drafts that adapt to diverse sponsor formats and workflows.
- It integrates seamlessly with Regulatory Information Management (RIM) systems, maintaining traceability and consistency across documents.
- The launch reinforces Indegene’s commitment to building AI-driven, domain-first solutions that help life sciences organizations modernize critical processes.